Introduction
Mites of the genus Blomia, including Blomia tropicalis and Blomia kulagini, are an important cause of IgE antibody responses among asthmatic patients in tropical and subtropical areas of the world. Exposure to B. tropicalis has been documented in houses from Hong Kong, Brazil, Venezuela, Colombia, Taiwan, India, Spain, Egypt and other countries [1] [2] [3] . In the United States, B. tropicalis has been identified in significant numbers in homes from Tampa Fla., New Orleans, La., Memphis, Tenn., Galveston, Tex., Delray Beach and San Diego, Calif. [4] . There has been increasing interest in the antigenic cross-reactivity between Blomia and Dermatophagoides spp., since exposure to both mite species is very common in such environments. Blomia spp. are the source of multiple allergens, the majority of which are species specific, as judged by results of serologic analysis and skin testing [3] [4] [5] [6] . However, at present no purified Blomia allergens have been reported. We have used molecular cloning techniques to further identify, characterize and sequence B. tropicalis allergens. Expression of the recombinant allergens will allow studies on the immune responses to B. tropicalis, and development of methods for assessing risk levels of exposure to this mite.
Methods and Results
IgE antibody responses to B. tropicalis were studied in a panel of sera of asthmatic patients from Brazil, Puerto Rico and Florida (n = 83), and compared to patients with asthma or atopic dermatitis from Charlottesville, Va., and England (n = 56), who were allergic to Dermatophogoidespteronys-sinus but unlikely to have been exposed to B. tropicalis. In the first group, 83% of B. tropicalis radioallergosorbent test (RAST)-positive patients also had a positive RAST to D. pteronyssinus. The ratio D. pteronyssinus/B. tropicalis RAST was > 10 in only 22% of the patients, probably reflecting exposure to both mite species. In contrast, although 50% of the Virginia/England D. pteronyssinus RAST-posi-tive subjects also had positive RAST to B. tropicalis, the ratio D. pteronyssinus/B. tropicalis RAST was > 10 in 68% of the patients and this difference was significant (p < 0.001). Our results are in keeping with previous studies and suggest that only 20-30% of B. tropicalis allergens may be shared with D. pteronyssinus. A cDNA library was prepared from B. tropicalis mRNA and screened with human IgE antibodies. A representative 522-bp cDNA clone was sequenced, containing a 432-bp open reading frame. The predicted amino acid sequence © 1995 S.K‚argerAG, Basel showed approximately 40% sequence homology to Der p 5, a 14-kd D. pteronyssinus allergen [7] . Plaque immunoassay results revealed that 70% of B. tropicalís RAST-positive asthmatic patients had IgE to the cloned protein. The B. tropicalis allergen has been designated as Bio 15. To obtain purified recombinant allergen, Bio t 5 cDNA was subcloned into the pGEX-4Tl vector and expressed in Escherichia coli as a fusion protein with glutathione S-transferase. Following thrombin cleavage, the B. tropicalis allergen was released and purified over glutathione agarose.
Results of an antigen-binding RIA showed that 12/12 B. tropicalis RAST-positive selected patients had IgE and IgG antibodies to recombinant Bio 15, whereas nonallergic controls showed no binding to this allergen. Discussion nus allergen Der p 5; however, no sequence homology with other proteins has been identified and the function of these proteins remains unknown. IgE to Der p 5 has been reported to be present in 50% > of D. pteronyssinus-aiiergic patients [7] , whereas IgE to Bio 15 appears to occur in a greater proportion of B. tropicαlis-aïïergic patients. This observation suggests that Bio 15 may be a more important allergen in B. tropicalis than the homologous molecule in D. pteronyssinus. Further studies using recombinant Bio t 5 and Der p 5 are underway in our laboratory to examine in detail the anti-genic cross-reactivity between these two proteins.
